143 related articles for article (PubMed ID: 21447734)
1. Mechanism-based inactivation of cytochrome P450 3A4 by mibefradil through heme destruction.
Foti RS; Rock DA; Pearson JT; Wahlstrom JL; Wienkers LC
Drug Metab Dispos; 2011 Jul; 39(7):1188-95. PubMed ID: 21447734
[TBL] [Abstract][Full Text] [Related]
2. Mechanism-based inactivation of cytochrome P450 3A4 by 17 alpha-ethynylestradiol: evidence for heme destruction and covalent binding to protein.
Lin HL; Kent UM; Hollenberg PF
J Pharmacol Exp Ther; 2002 Apr; 301(1):160-7. PubMed ID: 11907170
[TBL] [Abstract][Full Text] [Related]
3. The mibefradil derivative NNC55-0396, a specific T-type calcium channel antagonist, exhibits less CYP3A4 inhibition than mibefradil.
Bui PH; Quesada A; Handforth A; Hankinson O
Drug Metab Dispos; 2008 Jul; 36(7):1291-9. PubMed ID: 18411403
[TBL] [Abstract][Full Text] [Related]
4. Mechanism-based inactivation of cytochrome P-450-3A4 by mifepristone (RU486).
He K; Woolf TF; Hollenberg PF
J Pharmacol Exp Ther; 1999 Feb; 288(2):791-7. PubMed ID: 9918590
[TBL] [Abstract][Full Text] [Related]
5. The effect of ritonavir on human CYP2B6 catalytic activity: heme modification contributes to the mechanism-based inactivation of CYP2B6 and CYP3A4 by ritonavir.
Lin HL; D'Agostino J; Kenaan C; Calinski D; Hollenberg PF
Drug Metab Dispos; 2013 Oct; 41(10):1813-24. PubMed ID: 23886699
[TBL] [Abstract][Full Text] [Related]
6. The inactivation of cytochrome P450 3A5 by 17alpha-ethynylestradiol is cytochrome b5-dependent: metabolic activation of the ethynyl moiety leads to the formation of glutathione conjugates, a heme adduct, and covalent binding to the apoprotein.
Lin HL; Hollenberg PF
J Pharmacol Exp Ther; 2007 Apr; 321(1):276-87. PubMed ID: 17251390
[TBL] [Abstract][Full Text] [Related]
7. Mechanism-based inactivation of cytochrome P450 3A4 by lapatinib.
Teng WC; Oh JW; New LS; Wahlin MD; Nelson SD; Ho HK; Chan EC
Mol Pharmacol; 2010 Oct; 78(4):693-703. PubMed ID: 20624855
[TBL] [Abstract][Full Text] [Related]
8. Characterization of ritonavir-mediated inactivation of cytochrome P450 3A4.
Rock BM; Hengel SM; Rock DA; Wienkers LC; Kunze KL
Mol Pharmacol; 2014 Dec; 86(6):665-74. PubMed ID: 25274602
[TBL] [Abstract][Full Text] [Related]
9. The grapefruit juice effect is not limited to cytochrome P450 (P450) 3A4: evidence for bergamottin-dependent inactivation, heme destruction, and covalent binding to protein in P450s 2B6 and 3A5.
Lin HL; Kent UM; Hollenberg PF
J Pharmacol Exp Ther; 2005 Apr; 313(1):154-64. PubMed ID: 15608076
[TBL] [Abstract][Full Text] [Related]
10. Mechanism-based inactivation of cytochrome P450 2B6 by methadone through destruction of prosthetic heme.
Amunugama HT; Zhang H; Hollenberg PF
Drug Metab Dispos; 2012 Sep; 40(9):1765-70. PubMed ID: 22685215
[TBL] [Abstract][Full Text] [Related]
11. Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs.
Zhou S; Yung Chan S; Cher Goh B; Chan E; Duan W; Huang M; McLeod HL
Clin Pharmacokinet; 2005; 44(3):279-304. PubMed ID: 15762770
[TBL] [Abstract][Full Text] [Related]
12. Progress curve mechanistic modeling approach for assessing time-dependent inhibition of CYP3A4.
Burt HJ; Pertinez H; Säll C; Collins C; Hyland R; Houston JB; Galetin A
Drug Metab Dispos; 2012 Sep; 40(9):1658-67. PubMed ID: 22621802
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of cytochrome P450 (P450) 3A4 but not P450 3A5 by OSI-930, a thiophene-containing anticancer drug.
Lin HL; Zhang H; Medower C; Hollenberg PF; Johnson WW
Drug Metab Dispos; 2011 Feb; 39(2):345-50. PubMed ID: 21068193
[TBL] [Abstract][Full Text] [Related]
14. Prediction of the effect of erythromycin, diltiazem, and their metabolites, alone and in combination, on CYP3A4 inhibition.
Zhang X; Jones DR; Hall SD
Drug Metab Dispos; 2009 Jan; 37(1):150-60. PubMed ID: 18854379
[TBL] [Abstract][Full Text] [Related]
15. Automated screening with confirmation of mechanism-based inactivation of CYP3A4, CYP2C9, CYP2C19, CYP2D6, and CYP1A2 in pooled human liver microsomes.
Lim HK; Duczak N; Brougham L; Elliot M; Patel K; Chan K
Drug Metab Dispos; 2005 Aug; 33(8):1211-9. PubMed ID: 15860655
[TBL] [Abstract][Full Text] [Related]
16. Mechanism-based inactivation of cytochromes P450 2E1 and 2E1 T303A by tert-butyl acetylenes: characterization of reactive intermediate adducts to the heme and apoprotein.
Blobaum AL; Kent UM; Alworth WL; Hollenberg PF
Chem Res Toxicol; 2002 Dec; 15(12):1561-71. PubMed ID: 12482238
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic Studies of Cytochrome P450 3A4 Time-Dependent Inhibition Using Two Cysteine-Targeting Electrophiles.
Barr JT; Wang Z; Min X; Wienkers HJ; Rock BM; Rock DA; Wienkers LC
Drug Metab Dispos; 2020 Jun; 48(6):508-514. PubMed ID: 32193357
[TBL] [Abstract][Full Text] [Related]
18. Icotinib Induces Mechanism-Based Inactivation of Recombinant Human CYP3A4/5 Possibly via Heme Destruction by Ketene Intermediate.
Sun C; Zhao H; Li W; Jia Y; Yang Y; Peng Y; Zheng J
Drug Metab Dispos; 2021 Oct; 49(10):892-901. PubMed ID: 34312304
[TBL] [Abstract][Full Text] [Related]
19. Mechanism-based inactivation of cytochrome P450 3A4 by methylenedioxyphenyl lignans from Acanthopanax chiisanensis.
Yoo HH; Lee SH; Jin C; Kim DH
Planta Med; 2008 Jun; 74(8):822-7. PubMed ID: 18563665
[TBL] [Abstract][Full Text] [Related]
20. Metabolic activation of nevirapine in human liver microsomes: dehydrogenation and inactivation of cytochrome P450 3A4.
Wen B; Chen Y; Fitch WL
Drug Metab Dispos; 2009 Jul; 37(7):1557-62. PubMed ID: 19364830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]